- $572.13m
- $462.72m
Annual balance sheet for Zura Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.729 | 0.014 | 99.8 | 176 | 109 |
| Prepaid Expenses | |||||
| Total Current Assets | 1.15 | 0.033 | 101 | 179 | 112 |
| Net Property, Plant And Equipment | — | — | — | 0.091 | 0.126 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 141 | 142 | 101 | 180 | 114 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.272 | 1.83 | 20.3 | 19.5 | 12.4 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 10.4 | 7.76 | 41.5 | 32.7 | 12.4 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 130 | 134 | 59.3 | 147 | 102 |
| Total Liabilities & Shareholders' Equity | 141 | 142 | 101 | 180 | 114 |
| Total Common Shares Outstanding |